Ser292

Site Information
sKPAsSKsPLGLEAG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4772805

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 )
Relevant cell line - cell type - tissue:	'3T3-L1, differentiated' (adipocyte) ( 4 , 6 ) , 32Dcl3 (myeloid) [FLT3 (mouse), transfection, chimera with human FLT3-ITD mutant (corresponding to wild type P36888 ( 11 ) , 32Dcl3 (myeloid) ( 11 ) , BaF3 ('B lymphocyte, precursor') [JAK3 (human), transfection] ( 1 ) , heart ( 7 ) , kidney ( 10 ) , liver ( 2 ) , macrophage-peritoneum ( 8 ) , MC3T3-E1 (preosteoblast) ( 5 ) , MEF (fibroblast) [TSC2 (mouse), homozygous knockout] ( 9 ) , MEF (fibroblast) ( 9 ) , pancreas ( 10 )

In vivo Characterization

Methods used to characterize site in vivo:

mass spectrometry ( 1 , 2 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 )

Relevant cell line - cell type - tissue:

'3T3-L1, differentiated' (adipocyte) ( 4 , 6 ) , 32Dcl3 (myeloid) [FLT3 (mouse), transfection, chimera with human FLT3-ITD mutant (corresponding to wild type P36888 ( 11 ) , 32Dcl3 (myeloid) ( 11 ) , BaF3 ('B lymphocyte, precursor') [JAK3 (human), transfection] ( 1 ) , heart ( 7 ) , kidney ( 10 ) , liver ( 2 ) , macrophage-peritoneum ( 8 ) , MC3T3-E1 (preosteoblast) ( 5 ) , MEF (fibroblast) [TSC2 (mouse), homozygous knockout] ( 9 ) , MEF (fibroblast) ( 9 ) , pancreas ( 10 )

Upstream Regulation
Regulatory protein:	RIPK3 (mouse) ( 8 )
Treatments:	insulin ( 6 )

References
1	Degryse S, et al. (2017) Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia. Leukemia 32 28852199 Curated Info
2	Robles MS, Humphrey SJ, Mann M (2017) Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology. Cell Metab 25, 118-127 27818261 Curated Info
3	Sacco F, et al. (2016) Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion. Nat Commun 7, 13250 27841257 Curated Info
4	Minard AY, et al. (2016) mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes. Cell Rep 17, 29-36 27681418 Curated Info
5	Williams GR, et al. (2016) Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics. Methods 92, 36-50 26160508 Curated Info
6	Humphrey SJ, et al. (2013) Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2. Cell Metab 17, 1009-20 23684622 Curated Info
7	Lundby A, et al. (2013) In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling. Sci Signal 6, rs11 23737553 Curated Info
8	Wu X, et al. (2012) Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol Cell Proteomics 11, 1640-51 22942356 Curated Info
9	Yu Y, et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-6 21659605 Curated Info
10	Huttlin EL, et al. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-89 21183079 Curated Info
11	Choudhary C, et al. (2009) Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 36, 326-39 19854140 Curated Info